Dana V. Rizk's clinical and research interests revolve around glomerular diseases and, in particular IgA Nephropathy. She is the principal investigator of several clinical trials and is part of multi-disciplinary translational research projects focused on the role of biomarkers in IgAN. She serves as the Director of Clinical Trials Research in the Division and as the Medical Director of the Clinical Trials Administrative Office on campus. On the education side, she is involved in residents' and fellows’ training and serves on the clinical competency committees of both programs. She has mentored many trainees in clinical research and has received numerous teaching awards. Dr. Rizk is a member-elect of the Southern Society of Clinical Investigation and is past President of the Southern American Federation of Medical Research.
Dana V. Rizk's clinical and research interests revolve around glomerular diseases and, in particular IgA Nephropathy. She is the principal investigator of several clinical trials and is part of multi-disciplinary translational research projects focused on the role of biomarkers in IgAN. She serves as the Director of Clinical Trials Research in the Division and as the Medical Director of the Clinical Trials Administrative Office on campus. On the education side, she is involved in residents' and fellows’ training and serves on the clinical competency committees of both programs. She has mentored many trainees in clinical research and has received numerous teaching awards. Dr. Rizk is a member-elect of the Southern Society of Clinical Investigation and is past President of the Southern American Federation of Medical Research.